Thermo Fisher Scientific Receives IVDD CE Mark for LC-MS Products
News Sep 11, 2015
Thermo Fisher Scientific has announced that it has received the in vitro diagnostics device (IVDD) CE mark for its Thermo Scientific Prelude MD HPLC, Endura MD mass spectrometer and ClinQuan MD software.
Available for general in vitro diagnostic use in Europe, clinical laboratories now have access to a high performance liquid chromatography, mass spectrometer and LC-MS software designed and manufactured for in vitro diagnostic use in analyzing patient samples as components of laboratory-developed tests.
The products will be exhibited at the 2nd Annual European Conference on Clinical Mass Spectrometry, MSACL EU 2015 Conference, Booth 12-13, and at the Salzburg Congress Centre, Salzburg, Austria.
"We're strongly committed to bringing the advantages of LC-MS to the clinical market," said Bradley Hart, strategic director, life sciences mass spectrometry, clinical markets, for Thermo Fisher. “These three products are part of a larger initiative to make mass spectrometry more useful and accessible to clinicians.”
Researchers have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.
A team led by Johns Hopkins Medicine researchers says it has identified two protein biomarkers in urine that may one day be used to better diagnose acute interstitial nephritis, an underdiagnosed but treatable kidney disorder that impairs renal function in the short term and can lead to chronic kidney disease, permanent damage or renal failure if left unchecked.READ MORE